Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Leukemia, Biphenotypic, Acute 1Insulin Resistance 1Hyperbilirubinemia 1Hyperandrogenism 1Hirsutism 1Dyslipidemias 1Carcinoma, Non-Small-Cell Lung 1Cachexia 1Burkitt Lymphoma 1

Interventions

Cyclophosphamide 23Dexamethasone 16Cytarabine 15Vincristine 14venetoclax 13Methotrexate 11Etoposide 10Doxorubicin 10Calcium Dobesilate 10dexamethasone acetate 9dexamethasone 21-phosphate 9auricularum 9Prednisone 9prednylidene 8merphos 8deltacortene 8Specimen Handling 8calaspargase pegol 7Mercaptopurine 7pegaspargase 6fludarabine phosphate 6Granulocyte Colony-Stimulating Factor 6Daunorubicin 6Biopsy 6Asparaginase 6fludarabine 5daratumumab 5azathiopurine 5Thioguanine 5Stem Cell Transplantation 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × Carnitine × 1 year × Clear all
NCT05602194 2026-06-02

Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma

Children's Oncology Group

Phase 3 Active not recruiting
440 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡